Interstitial pneumonitis as an adverse reaction to mTOR inhibitors.


INTRODUCTION mTOR (mammalian target of rapamycin) inhibitors sirolimus and everolimus, used as immunosuppressants in solid organ transplantation, may cause severe adverse effects, such as interstitial pneumonitis. INCIDENCE AND CLINICAL PRESENTATION: The estimated incidence of interstitial pneumonitis is 4-11% although it may be higher. Most reported cases… (More)
DOI: 10.3265/Nefrologia.pre2013.Jan.11439


Cite this paper

@article{MolasFerrer2013InterstitialPA, title={Interstitial pneumonitis as an adverse reaction to mTOR inhibitors.}, author={Gl{\`o}ria Molas-Ferrer and Dolors Soy-Muner and Helena Anglada-Mart{\'i}nez and Gisela Riu-Viladoms and Anna Estefanell-Tejero and Josep Ribas-Sala}, journal={Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia}, year={2013}, volume={33 3}, pages={297-300} }